Clinical approach to infection in the compromised host /
Saved in:
| Edition: | 4th ed. |
|---|---|
| Imprint: | New York : Kluwer Academic/Plenum, c2002. |
| Description: | xxv, 719 p. : ill. (some col.) ; 28 cm. |
| Language: | English |
| Subject: | |
| Format: | E-Resource Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/4829027 |
Table of Contents:
- 1. Introduction
- 2. Defects in Host Defense Mechanisms
- 1.. Colonization
- 2.. First Line of Defense
- 3.. Second Line of Defense
- 4.. Factors that Influence the Quality of Host Defense
- 5.. Diseases that Affect Host Defense
- 6.. Immunosuppressive Drugs
- 7.. Plasmapheresis
- 8.. Radiation
- 9.. Attempts to Strengthen Host Defense
- References
- 3. Mucocutaneous Infections in the Immunocompromised Host
- 1.. Introduction
- 2.. Skin as a Barrier to Infection
- 3.. Types of Skin Infection
- 4.. Diagnostic Aspects of Skin Infections in the Compromised Patient
- 5.. Opportunistic Infections by Pathogen
- 6.. Diagnostic Aspects of Skin Infections in the Compromised Patient
- 7.. Inflammatory Disorders that Simulate Infection in the Compromised Host
- 8.. Conclusion
- Bibliography
- References
- 4. Clinical Approach to the Compromised Host with Fever and Pulmonary Infiltrates
- 1.. The Febrile Pneumonitis Syndrome and Its Importance
- 2.. Overview of the Infectious Causes of the Febrile Pneumonitis Syndrome in the Immunocompromised Host
- 3.. Overview of Noninfectious Causes of the Febrile Pneumonitis Syndrome
- 4.. Radiologic Clues to the Diagnosis of the Febrile Pneumonitis Syndrome
- 5.. Specific Diagnosis
- 6.. Superinfection
- References
- 5. Central Nervous System Infection in the Immunocompromised Host
- 1.. Introduction
- 2.. Viral Infections
- 3.. Bacterial Infections
- 4.. Fungal Infections
- 5.. Protozoal Infections
- References
- 6. Fungal Infections in the Immunocompromised Host
- 1.. Introduction
- 2.. Antifungal Prophylaxis in the Immunocompromised Host
- 3.. Empiric Antifungal Therapy in Neutropenic Patients with Persistent Fever
- 4.. Candidiasis
- 5.. Aspergillosis
- 6.. Zygomycosis
- 7.. Fusariosis
- 8.. Cryptococcosis
- 9.. Histoplasmosis
- 10.. Coccidioidomycosis
- 11.. Blastomycosis
- 12.. Unusual Fungal Pathogens
- 13.. Antifungal Agents
- References
- 7. Mycobacterial and Nocardial Diseases in the Compromised Host
- 1.. Introduction
- 2.. Microbiologic Classification and Clinical Syndromes
- 3.. Pathogenesis and Epidemiology
- 4.. Treatment of Tuberculosis, Drug-Resistant Tuberculosis, and Alternative Antituberculosis Chemotherapy
- 5.. Nocardiosis
- References
- 8. Pneumocystis carinii and Parasitic Infections in the Immunocompromised Host
- 1.. Introduction
- 2.. Pneumocystis carinii
- 3.. Toxoplasma gondii
- 4.. Cryptosporidium Species
- 5.. Isospora belli
- 6.. Microsporidia
- 7.. Strongyloides stercoralis
- 8.. Entamoeba histolytica and Amebiasis
- 9.. Primary Amebic Meningoencephalitis
- 10.. Leishmaniasis
- 11.. Other Parasitic Diseases of the Immunocompromised Host
- References
- 9. Viral Hepatitis in the Compromised Host
- 1.. Introduction
- 2.. Role of Immunologic Mechanisms in the Pathogenesis of Viral Hepatitis
- 3.. Viral Hepatitis in the Immunocompromised Host
- 4.. Prevention
- 5.. Summary
- References
- 10. The Herpesviruses
- 1.. General Characteristics of Herpesviruses
- 2.. Characteristics of Particular Herpesviruses
- References
- 11. Morbidity in Compromised Patients Related to Viruses Other than Herpes Group and Hepatitis Viruses
- 1.. Introduction
- 2.. DNA Viruses
- 3.. RNA Viruses
- References
- 12. Pathogenesis and Clinical Manifestations of HIV-1 Infection
- 1.. Epidemiology of HIV-1 Infection
- 2.. Primary HIV-1 Infection
- 3.. Pathogenesis of HIV-1 Infection
- 4.. Neurologic Manifestations of HIV-1 Infection
- 5.. Clinical Manifestations of AIDS Dementia Complex
- 6.. Cachexia and Wasting in HIV-1 Infection
- 7.. Metabolic Disturbances
- 8.. Principles of Antiretroviral Chemotherapy
- 9.. Primary and Secondary Prophylaxis of Opportunistic Infections in HIV-1-Infected Individuals
- References
- 13. Infectious Complications in Children with Cancer and Children with Human Immunodeficiency Virus Infection
- 1.. Introduction
- 2.. Background
- 3.. Interface between Cancer and Infections
- 4.. Perturbations of Host Defense that Contribute to Infection
- 5.. Fever
- 6.. Immunizations
- 7.. Infection Prophylaxis
- 8.. Use of Growth Factors
- 9.. Conclusions
- References
- 14. Infections Complicating Congenital Immunodeficiency Syndromes
- 1.. Introduction
- 2.. Aim of Therapy in Congenital Immunodeficiency Diseases
- 3.. Specific Infections in Immunodeficiency Syndromes
- References
- 15. Management of Infections in Leukemia and Lymphoma
- 1.. Introduction
- 2.. Host Defenses against Infection in Leukemias and Lymphomas
- 3.. The Role of Infection in Mortality from Leukemia and Lymphomas
- 4.. Problems with the Interpretation of Fever and Infection Incidence Data in Neutropenic States
- 5.. Causes of Fever in Leukemia and Lymphoma
- 6.. Site of Involvement and the Nature of the Microbial Pathogen(s)
- 7.. Synthesis
- 8.. Summary of Recommended Therapeutic Strategies
- 9.. Approach to the Splenectomized Patient
- 10.. Neutrophil Transfusions in the Treatment and Prophylaxis of Infection
- 11.. Immunoprophylaxis and Immunotherapy of Infection
- References
- 16. Infection in Hematopoietic Stem Cell Transplantation
- 1.. Introduction
- 2.. Transplantation Techniques
- 3.. Recovery of Host Defenses
- 4.. Phases of Infection after HSCT
- 5.. Phase I: Infections between Conditioning and Engraftment
- 6.. Phase II: Infections between Engraftment and Day 100
- 7.. Phase III: After 100 Days
- 8.. Other Infections
- 9.. Pretransplant Infectious Disease Considerations
- 10.. Infection Control Programs and Surveillance
- 11.. Conclusions and Future Considerations
- References
- 17. Infection in the Organ Transplant Recipient
- 1.. Introduction
- 2.. Risk of Infection in the Organ Transplant Recipient
- 3.. Timetable of Infection in the Organ Transplant Recipient
- 4.. Infection Occurring in the First Month Posttransplant
- 5.. Infection 1 to 6 Months Posttransplant
- 6.. Infection in Organ Transplant Patients More than 6 Months Posttransplant
- 7.. Infectious Disease Problems of Particular Importance in the Organ Transplant Patient
- 8.. Vaccine Use in Organ Transplant Recipients
- 9.. Summary and Prospects for the Future
- References
- 18. Surgical Aspects of Infection in the Compromised Host
- 1.. Introduction
- 2.. Diagnostic Approach
- 3.. Preoperative Preparation
- 4.. Intraoperative Considerations
- 5.. Postoperative Management
- 6.. Conclusions
- References
- Color Plates
- Index
